Back to Journals » Drug Design, Development and Therapy » Volume 9

Antibiotic-modifying activity of riachin, a non-cyanogenic cyanoglycoside extracted from Bauhinia pentandra

Authors Farias P, Figueredo F, Lucas A, Barbosa de Moura R, Coutinho HDM, da Silva T, Martin AL, de França Fonteles M

Received 15 March 2015

Accepted for publication 8 April 2015

Published 15 June 2015 Volume 2015:9 Pages 3067—3072


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Professor Shu-Feng Zhou

Pablo Antonio Maia de Farias,1,3 Fernando Gomes Figueredo,2,3 Aline Maria Brito Lucas,3 Rafael Barbosa de Moura,3 Henrique Douglas Melo Coutinho,2 Tania Maria Sarmento da Silva,4 Ana Luiza de Aguiar Rocha Martin,2,3 Marta Maria de França Fonteles1

Development and Technological Innovation in Medicines, Universidade Federal do Ceará – UFC, Fortaleza-CE, 2College of Biomedicine, Faculdade Leão Sampaio-FLS, 3College of Pharmacy, Faculdade de Medicina Estácio de Juazeiro do Norte-Estácio, Juazeiro do Norte-CE, 4Department of Molecular Sciences, Universidade Federal Rural de Pernambuco, Recife, PE, Brazil

Background: The search for new active compounds from the Brazilian flora has intensified in recent years, especially for new drugs with antibiotic potential. Accordingly, the aim of this study was to determine whether riachin has antibiotic activity in itself or is able to modulate the activity of conventional antibiotics.
Methods: A non-cyanogenic cyanoglycoside known as riachin was isolated from Bauhinia pentandra, and was tested alone and in combination with three antibiotics (clindamycin, amikacin, and gentamicin) against multiresistant bacterial strains (Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus).
Results: Riachin did not show significant antibiotic activity when tested alone against any strain (P>0.05). However, when combined with conventional antibiotics, it showed drug-modifying activity against strains of S. aureus exposed to clindamycin (P<0.001) as well as against P. aeruginosa exposed to amikacin (P<0.001). Although riachin did not show direct antibiotic activity, it had synergistic activity when combined with amikacin or clindamycin. The mechanism of action of this synergism is under investigation.
Conclusion: The results of this work demonstrate that some substances of natural origin can enhance the effectiveness of certain antibiotics, which means a substantial reduction in the drug dose required and possibly in consequent adverse events for patients.

Keywords: riachin, Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]